Trial Outcomes & Findings for Pain Management for Pectus Excavatum Repair (NCT NCT00413582)

NCT ID: NCT00413582

Last Updated: 2012-01-16

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

110 participants

Primary outcome timeframe

1 week

Results posted on

2012-01-16

Participant Flow

Patients were recruited from patients undergoing pectus excavatum repair.

All patients who consented were enrolled

Participant milestones

Participant milestones
Measure
Epidural Group
Epidural analgesia arm of study
PCA Group
IV narcotic analgesia arm of study
Overall Study
STARTED
55
55
Overall Study
Completion of Study
55
55
Overall Study
COMPLETED
55
55
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Pain Management for Pectus Excavatum Repair

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Epidural Group
n=55 Participants
Epidural analgesia arm of study
PCA Group
n=55 Participants
IV narcotic analgesia arm of study
Total
n=110 Participants
Total of all reporting groups
Age, Categorical
<=18 years
49 Participants
n=99 Participants
53 Participants
n=107 Participants
102 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
n=99 Participants
2 Participants
n=107 Participants
8 Participants
n=206 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age Continuous
15.3 years
STANDARD_DEVIATION 2.84 • n=99 Participants
13.55 years
STANDARD_DEVIATION 2.91 • n=107 Participants
14.43 years
STANDARD_DEVIATION 2.99 • n=206 Participants
Sex: Female, Male
Female
10 Participants
n=99 Participants
18 Participants
n=107 Participants
28 Participants
n=206 Participants
Sex: Female, Male
Male
45 Participants
n=99 Participants
37 Participants
n=107 Participants
82 Participants
n=206 Participants
Region of Enrollment
United States
55 participants
n=99 Participants
55 participants
n=107 Participants
110 participants
n=206 Participants

PRIMARY outcome

Timeframe: 1 week

Outcome measures

Outcome measures
Measure
Epidural Group
n=55 Participants
Epidural analgesia arm of study
PCA Group
n=55 Participants
IV narcotic analgesia arm of study
Length of Hospitalization
4.54 days
Standard Deviation 1.01
4.25 days
Standard Deviation 1.00

SECONDARY outcome

Timeframe: 1 week

Outcome measures

Outcome measures
Measure
Epidural Group
n=55 Participants
Epidural analgesia arm of study
PCA Group
n=55 Participants
IV narcotic analgesia arm of study
Time in the Operating Room
1.97 hours
Standard Deviation .35
1.58 hours
Standard Deviation .33

Adverse Events

Epidural Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

PCA Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Shawn D. St. Peter, MD

Children's Mercy Hospital

Phone: 816-983-6479

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place